CRYOGLOBULINEMIA VASCULITIS

Clinical trials for CRYOGLOBULINEMIA VASCULITIS explained in plain language.

Never miss a new study

Get alerted when new CRYOGLOBULINEMIA VASCULITIS trials appear

Sign up with your email to follow new studies for CRYOGLOBULINEMIA VASCULITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New hope for Hard-to-Treat vasculitis: IL-2 shows promise

Disease control Completed

This study tested a low dose of interleukin-2 (IL-2) in 10 people with hepatitis C-related vasculitis that did not improve with standard treatments. The goal was to see if IL-2 could boost regulatory T cells to calm the immune system and reduce inflammation. Researchers monitored…

Matched conditions: CRYOGLOBULINEMIA VASCULITIS

Phase: PHASE1, PHASE2 • Sponsor: French National Agency for Research on AIDS and Viral Hepatitis • Aim: Disease control

Last updated May 26, 2026 10:34 UTC

CRYOGLOBULINEMIA VASCULITIS

Get alerted when new CRYOGLOBULINEMIA VASCULITIS trials appear

New hope for Hard-to-Treat vasculitis: IL-2 shows promise